Literature DB >> 3736498

Routine use of counterimmunoelectrophoresis for the detection of pneumococcal antigen in sputum.

C H Ericsson, H O Hallander, A Rosen, A M Sjögren, I Sjögren.   

Abstract

Sputum samples obtained routinely for culture from patients at a thoracic department were also examined for pneumococcal antigen by means of counterimmunoelectrophoresis (CIE), using a polyvalent antipneumococcal type serum (omniserum). Pneumococci were found in 1.3% of the 880 cultures, whereas pneumococcal antigen was detected with CIE in 6.5%. The validity of these findings was tested by correlating them with the presence of clinical symptoms in those with positive tests and also by antigen detection in ELISA using monoclonal antibodies specific for the C-polysaccharide common to all types of pneumococci. Clinical findings corresponding to confirmed or probable current chest infection were found in 36 of the 48 patients with positive CIE. ELISA was positive in 33 of the 38 patients with positive CIE who were tested. Although the study deals with an unselected material of chest patients, it indicates that CIE is a sensitive method and that it is independent of current antibiotic treatment. Pneumococcal infection is probably of importance in exacerbations of chronic obstructive lung disease, but the clinical usefulness of detecting pneumococcal and other antigens in this patient group needs to be studied further.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736498     DOI: 10.1007/bf02123732

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  30 in total

1.  Diagnosis of pneumococcal pneumonia by antigen detection in sputum.

Authors:  J Miller; M A Sande; J M Gwaltney; J O Hendley
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

2.  Counter-current immunoelectrophoresis for the diagnosis of pneumococcal chest infection.

Authors:  M El-Refaie; C Dulake
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

3.  Comparison of sputum counterimmunoelectrophoresis and culture in diagnosis of pneumococcal pneumonia.

Authors:  B A Downes; P D Ellner
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

4.  Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.

Authors:  J Yother; C Forman; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

5.  Indirect sandwich enzyme-linked immunosorbent assay for rapid detection of Streptococcus pneumoniae type 3 antigen.

Authors:  D L Drow; D D Manning
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

6.  Pneumococcal antigen in lobar pneumonia.

Authors:  P Tugwell; B M Greenwood
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

7.  Counterimmunoelectrophoresis of sputum and blood for the diagnosis of chest infections caused by pneumococci or Haemophilus influenzae.

Authors:  B Trollfors; E Berntsson; B Elgefors; B Kaijser
Journal:  Scand J Infect Dis       Date:  1979

8.  Sputum counterimmunoelectrophoresis in the diagnosis of pneumococcal pneumonia.

Authors:  R E Schmid; J P Anhalt; A D Wold; T F Keys; J A Washington
Journal:  Am Rev Respir Dis       Date:  1979-03

9.  Coagglutination and counterimmunoelectrophoresis for detection of pneumococcal antigens in the sputum of pneumonia patients.

Authors:  E A Edwards; J D Coonrod
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more
  1 in total

1.  Detection of Bacteroides fragilis endotoxin in amniotic fluid by counterimmunoelectrophoresis.

Authors:  I Beckmann; K de Graaff; F Meisel-Mikołajczyk; H C Wallenburg
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.